Header cover image

Pharmaceuticals & Biotech Consumer Discretionary

Results

1272

0 new

All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.

1,272 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

SIGA

SIGA Technologies
US$6.96-17.4%32.6%US$496.7mn/aPE5.9xS6.7%8.6%

HARP

Harpoon Therapeutics
US$23.010.2%243.4%US$492.3mUS$23.77PS13.2xE10.6%n/a

SLRN

Acelyrin
US$4.93-8.5%-51.5%US$492.1mUS$10.50PB0.9xE9.1%n/a

QTRX

Quanterix
US$12.73-12.4%-53.1%US$488.6mUS$22.00PS3.8xE29.6%n/a

CTNM

Contineum Therapeutics
US$18.84-5.0%n/aUS$484.6mUS$28.67PB2.2xS-6.5%n/a

AVXL

Anavex Life Sciences
US$5.680.7%-13.3%US$481.6mUS$35.47PB3.7xE61.5%n/a

ALEC

Alector
US$4.92-9.7%-20.5%US$478.8mUS$15.44PS8.7xE61.1%n/a

PACB

Pacific Biosciences of California
US$1.750.6%-78.3%US$476.9mUS$3.00PS2.5xE35.2%n/a

MNMD

Mind Medicine (MindMed)
US$5.85-2.0%86.9%US$476.4mUS$26.25PB2.4xE32.5%n/a

CMPS

COMPASS Pathways
US$6.81-2.4%-0.9%US$465.7mUS$38.22PB2.1xE39.4%n/a

ALT

Altimmune
US$6.47-10.1%154.7%US$459.8mUS$20.57PS1124.3xE20.2%n/a

TECX

Tectonic Therapeutic
US$30.6046.3%n/aUS$450.9mUS$60.00PB2.7xE-28.3%n/a

ABSI

Absci
US$3.97-8.1%200.8%US$450.8mUS$7.99PS138.7xE20.1%n/a

CRMD

CorMedix
US$8.059.1%117.6%US$449.7mUS$12.50PS557.8xE65.6%n/a

AURA

Aura Biosciences
US$9.03-5.6%0.7%US$447.9mUS$21.00PB2.3xE-9.9%n/a

GRAL

GRAIL
US$14.403.2%n/aUS$447.1mn/aPS4.1xn/an/a

SAGE

Sage Therapeutics
US$7.290.8%-63.1%US$445.1mUS$14.33PS4.6xE39.3%n/a

AQST

Aquestive Therapeutics
US$4.72-3.3%237.1%US$429.8mUS$9.06PS7.4xE37.6%n/a

XERS

Xeris Biopharma Holdings
US$2.874.0%64.0%US$427.6mUS$4.67PS2.4xE66.1%n/a

EYPT

EyePoint Pharmaceuticals
US$7.98-3.7%2.3%US$427.1mUS$36.64PS8.5xE3.1%n/a

TIL

Instil Bio
US$65.62-1.0%666.6%US$426.8mUS$103.67PB2.2xE63.2%n/a

TSHA

Taysha Gene Therapies
US$2.07-3.7%-34.5%US$424.2mUS$6.41PS33xE14.0%n/a

VERV

Verve Therapeutics
US$4.98-4.0%-62.4%US$421.4mUS$26.01PS20.4xE-11.6%n/a

LRMR

Larimar Therapeutics
US$6.57-7.1%66.3%US$419.2mUS$20.52PB2xE-8.0%n/a
Page 13 of 53
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.